Catalyst
Pit
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
☰
LXEO
Lexeo Therapeutics, Inc.
NASDAQ · Biological Products, (No Diagnostic Substances)
Last close
$3.38
· 2026-09-30
ABOUT
Exchange
NASDAQ
Sector
Healthcare
Industry
Biological Products, (No Diagnostic Substances)
Market cap
$277.32M
RECENT INSIDER TRADES
2026-09-28
· Townsend Richard Nolan
(Chief Executive Officer)
· OTHER
2026-09-28
· Otero Jose Manuel
(Chief Operating Officer)
· OTHER
2026-09-28
· Bhalla Narinder Pal
(Chief Medical Officer)
· OTHER
2026-08-19
· Otero Jose Manuel
(Chief Operating Officer)
· SELL
2026-08-19
· Tamayo Louis Edward
(Chief Financial Officer)
· SELL
INSTITUTIONAL OWNERSHIP
Institutional holders
150
Shares held
98,052,188
Value
$491.70M
Percent of shares outstanding
119.51%
As of quarter end
2026-06-30
RECENT NEWS
Lexeo Therapeutics to Participate in the Chardan Healthcare Conference
Lexeo Therapeutics to present LX2006 at MDS 2026 congress
Lexeo Therapeutics to acquire Mantle Therapeutics
Apertura Gene Therapy grants Lexeo access to TfR1 CapX for Friedreich ataxia program
Lexeo Therapeutics to Participate in the Stifel 2026 Virtual Cardiometabolic Forum
Catalyst
Pit
Features
Coming soon
Pricing
Coming soon
Privacy
Terms
Disclaimer
Affiliate Terms
Contact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Lexeo Therapeutics, Inc. (LXEO) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit